64 research outputs found

    Synthesis and characterization of amorphous astrominerals

    Get PDF
    Abstract only availableAsymptotic Giant Branch (AGB) stars are the main contributors of solid material (dust) to the interstellar medium. The dust forms as gas escaping from the star cools and condenses to form a circumstellar dust shell. Around oxygen-rich stars, most of the dust particles are silicates, but important questions remain about which minerals are formed and whether the grains are crystalline or amorphous (glassy). Dust grains that form below the glass transition temperature (Tg) of a particular mineral should be amorphous, while those that form much above Tg should be crystalline. The most refractory silicates predicted to form are members of the Melilite group of minerals, whose end-members are Gehlenite (Ca2Al2SiO7), Sodium Melilite (CaNaAlSi2O7) and Åkermanite (Ca2MgSiO7). Synthetic glasses corresponding to these end-member compositions were synthesized from oxide and carbonate powders by melting in Pt crucibles in a muffle furnace at temperatures up to 1650˚C. The viscosity of the melts was measured by the parallel-plate technique in the temperature range 655 to 900˚C, over the viscosity range 2x107 to 91012 Pa s. The viscosity-temperature data were interpolated to determine Tg for each glass, taken to be the temperature at which the viscosity is 1012 Pa s. Two naturally occurring mineral samples, of åkermanite and gehlenite, were also melted. At higher temperatures and lower viscosities than about 108 Pa s, crystallization is expected to be rapid relative to the timescale of cooling in circumstellar dust shells. Our experimentally determined glass transition temperatures therefore provide constraints on the nature (crystalline vs amorphous) of several refractory astrominerals predicted to be found in these shells. Future studies of these glasses will include infrared spectroscopy, in order to better interpret astronomical spectra and test for the presence of amorphous dust with these compositions. The results will be used to test competing models for circumstellar dust formation.Missouri Academy at Northwest Missouri State Universit

    The Cosmic Crystallinity Conundrum: Clues from IRAS 17495-2534

    Full text link
    Since their discovery, cosmic crystalline silicates have presented several challenges to understanding dust formation and evolution. The mid-infrared spectrum of IRAS 17495-2534, a highly obscured oxygen-rich asymptotic giant branch (AGB) star, is the only source observed to date which exhibits a clear crystalline silicate absorption feature. This provides an unprecedented opportunity to test competing hypotheses for dust formation. Observed spectral features suggest that both amorphous and crystalline dust is dominated by forsterite (Mg\_2 SiO\_4) rather than enstatite (MgSiO\_3) or other silicate compositions. We confirm that high mass-loss rates should produce more crystalline material, and show why this should be dominated by forsterite. The presence of Mg\_2 SiO\_4 glass suggests that another factor (possibly C/O) is critical in determining astromineralogy. Correlation between crystallinity, mass-loss rate and initial stellar mass suggests that only the most massive AGB stars contribute significant quantities of crystalline material to the interstellar medium, resolving the conundrum of its low crystallinity.Comment: 12 pages, 2 figure

    The Long-Baseline Neutrino Experiment: Exploring Fundamental Symmetries of the Universe

    Get PDF
    The preponderance of matter over antimatter in the early Universe, the dynamics of the supernova bursts that produced the heavy elements necessary for life and whether protons eventually decay --- these mysteries at the forefront of particle physics and astrophysics are key to understanding the early evolution of our Universe, its current state and its eventual fate. The Long-Baseline Neutrino Experiment (LBNE) represents an extensively developed plan for a world-class experiment dedicated to addressing these questions. LBNE is conceived around three central components: (1) a new, high-intensity neutrino source generated from a megawatt-class proton accelerator at Fermi National Accelerator Laboratory, (2) a near neutrino detector just downstream of the source, and (3) a massive liquid argon time-projection chamber deployed as a far detector deep underground at the Sanford Underground Research Facility. This facility, located at the site of the former Homestake Mine in Lead, South Dakota, is approximately 1,300 km from the neutrino source at Fermilab -- a distance (baseline) that delivers optimal sensitivity to neutrino charge-parity symmetry violation and mass ordering effects. This ambitious yet cost-effective design incorporates scalability and flexibility and can accommodate a variety of upgrades and contributions. With its exceptional combination of experimental configuration, technical capabilities, and potential for transformative discoveries, LBNE promises to be a vital facility for the field of particle physics worldwide, providing physicists from around the globe with opportunities to collaborate in a twenty to thirty year program of exciting science. In this document we provide a comprehensive overview of LBNE's scientific objectives, its place in the landscape of neutrino physics worldwide, the technologies it will incorporate and the capabilities it will possess.Comment: Major update of previous version. This is the reference document for LBNE science program and current status. Chapters 1, 3, and 9 provide a comprehensive overview of LBNE's scientific objectives, its place in the landscape of neutrino physics worldwide, the technologies it will incorporate and the capabilities it will possess. 288 pages, 116 figure

    Penetration of crustal melt beyond the Kunlun Fault into northern Tibet

    Get PDF
    The weak lithosphere of the Tibetan plateau is surrounded by rigid crustal blocks1 and the transition between these regimes plays a key role in the ongoing collision between India and Eurasia. Geophysical data2,3,4,5 and magmatic evidence6,7 support the notion that partial melt exists within the anomalously hot7,8 crust of northern Tibet. The Kunlun Fault, which accommodates the plateau’s eastward extrusion, has been identified as a significant rheological boundary4 between weak, warm Tibetan crust8 and the rigid eastern Kunlun–Qaidam block. Here we present reanalyses and remodelling of existing magnetotelluric data4, using an anisotropy code9 to obtain revised resistivity models. We find unequivocal evidence for anisotropy in conductivity at the northern edge of the Tibetan plateau. We interpret this anisotropy as the signature of intrusion of melt that penetrates north from the Tibetan plateau and weakens the crust beneath the Kunlun Shan. We suggest that our identification of a melt intrusion at the northern edge of the Tibetan plateau compromises the previous identification of the Kunlun Fault as an important rheological boundary. We conclude that the crustal melt penetration probably characterizes the growth of the plateau10 to the north, as well as accommodating the north–south crustal shortening in Tibet

    Implementation of corticosteroids in treating COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK:prospective observational cohort study

    Get PDF
    BACKGROUND: Dexamethasone was the first intervention proven to reduce mortality in patients with COVID-19 being treated in hospital. We aimed to evaluate the adoption of corticosteroids in the treatment of COVID-19 in the UK after the RECOVERY trial publication on June 16, 2020, and to identify discrepancies in care. METHODS: We did an audit of clinical implementation of corticosteroids in a prospective, observational, cohort study in 237 UK acute care hospitals between March 16, 2020, and April 14, 2021, restricted to patients aged 18 years or older with proven or high likelihood of COVID-19, who received supplementary oxygen. The primary outcome was administration of dexamethasone, prednisolone, hydrocortisone, or methylprednisolone. This study is registered with ISRCTN, ISRCTN66726260. FINDINGS: Between June 17, 2020, and April 14, 2021, 47 795 (75·2%) of 63 525 of patients on supplementary oxygen received corticosteroids, higher among patients requiring critical care than in those who received ward care (11 185 [86·6%] of 12 909 vs 36 415 [72·4%] of 50 278). Patients 50 years or older were significantly less likely to receive corticosteroids than those younger than 50 years (adjusted odds ratio 0·79 [95% CI 0·70–0·89], p=0·0001, for 70–79 years; 0·52 [0·46–0·58], p80 years), independent of patient demographics and illness severity. 84 (54·2%) of 155 pregnant women received corticosteroids. Rates of corticosteroid administration increased from 27·5% in the week before June 16, 2020, to 75–80% in January, 2021. INTERPRETATION: Implementation of corticosteroids into clinical practice in the UK for patients with COVID-19 has been successful, but not universal. Patients older than 70 years, independent of illness severity, chronic neurological disease, and dementia, were less likely to receive corticosteroids than those who were younger, as were pregnant women. This could reflect appropriate clinical decision making, but the possibility of inequitable access to life-saving care should be considered. FUNDING: UK National Institute for Health Research and UK Medical Research Council

    Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission

    Get PDF
    Abstract Admission procalcitonin measurements and microbiology results were available for 1040 hospitalized adults with coronavirus disease 2019 (from 48 902 included in the International Severe Acute Respiratory and Emerging Infections Consortium World Health Organization Clinical Characterisation Protocol UK study). Although procalcitonin was higher in bacterial coinfection, this was neither clinically significant (median [IQR], 0.33 [0.11–1.70] ng/mL vs 0.24 [0.10–0.90] ng/mL) nor diagnostically useful (area under the receiver operating characteristic curve, 0.56 [95% confidence interval, .51–.60]).</jats:p

    Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

    Get PDF
    Background: Microbiological characterisation of co-infections and secondary infections in patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe microbiologically confirmed co-infections and secondary infections, and antimicrobial use, in patients admitted to hospital with COVID-19. Methods: The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) WHO Clinical Characterisation Protocol UK (CCP-UK) study is an ongoing, prospective cohort study recruiting inpatients from 260 hospitals in England, Scotland, and Wales, conducted by the ISARIC Coronavirus Clinical Characterisation Consortium. Patients with a confirmed or clinician-defined high likelihood of SARS-CoV-2 infection were eligible for inclusion in the ISARIC WHO CCP-UK study. For this specific study, we excluded patients with a recorded negative SARS-CoV-2 test result and those without a recorded outcome at 28 days after admission. Demographic, clinical, laboratory, therapeutic, and outcome data were collected using a prespecified case report form. Organisms considered clinically insignificant were excluded. Findings: We analysed data from 48 902 patients admitted to hospital between Feb 6 and June 8, 2020. The median patient age was 74 years (IQR 59–84) and 20 786 (42·6%) of 48 765 patients were female. Microbiological investigations were recorded for 8649 (17·7%) of 48 902 patients, with clinically significant COVID-19-related respiratory or bloodstream culture results recorded for 1107 patients. 762 (70·6%) of 1080 infections were secondary, occurring more than 2 days after hospital admission. Staphylococcus aureus and Haemophilus influenzae were the most common pathogens causing respiratory co-infections (diagnosed ≤2 days after admission), with Enterobacteriaceae and S aureus most common in secondary respiratory infections. Bloodstream infections were most frequently caused by Escherichia coli and S aureus. Among patients with available data, 13 390 (37·0%) of 36 145 had received antimicrobials in the community for this illness episode before hospital admission and 39 258 (85·2%) of 46 061 patients with inpatient antimicrobial data received one or more antimicrobials at some point during their admission (highest for patients in critical care). We identified frequent use of broad-spectrum agents and use of carbapenems rather than carbapenem-sparing alternatives. Interpretation: In patients admitted to hospital with COVID-19, microbiologically confirmed bacterial infections are rare, and more likely to be secondary infections. Gram-negative organisms and S aureus are the predominant pathogens. The frequency and nature of antimicrobial use are concerning, but tractable targets for stewardship interventions exist. Funding: National Institute for Health Research (NIHR), UK Medical Research Council, Wellcome Trust, UK Department for International Development, Bill &amp; Melinda Gates Foundation, EU Platform for European Preparedness Against (Re-)emerging Epidemics, NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool, and NIHR HPRU in Respiratory Infections at Imperial College London
    corecore